AffyImmune Promotes Dr. Deyaa Adib to Chief Medical Officer AffyImmune Therapeutics has appointed Dr. Deyaa Adib as Chief Medical Officer. His extensive oncology experience aims to enhance clinical development strategies for cancer therapies.

AffyImmune Promotes Dr. Deyaa Adib to Chief Medical Officer #USA #AffyImmune #Deyaa_Adib #CAR_T_Therapy #Natick,_Massachusetts